longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CBT

CBT
79.3501.21%( -0.970 )

LongbridgeAI

Top Executive Makes Bold Move With Major Cabot Stock Sale

Tip Ranks
Aug 12, 2026 at 02:11 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Cabot Corporation's President and CEO, Sean Keohane, sold 91,923 shares worth approximately $7.94 million on August 11, 2026. This significant insider transaction follows the company's Q3 earnings report, where adjusted EPS beat consensus and revenue exceeded expectations, driven by strong Performance Chemicals and battery materials growth. Despite tightening FY26 EPS guidance due to pressures in Reinforcement Materials and raw material volatility, analysts maintain mixed views, with Spark labeling CBT an 'Outperform' based on improved financial strength and technical positioning.

New insider activity at Cabot ( (CBT) ) has taken place on August 11, 2026.

Claim 55% Off TipRanks

  • Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
  • Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Cabot’s President and CEO, Sean Keohane, recently executed a significant insider transaction, selling 91,923 shares of Cabot stock. The sale, valued at $7,942,147, highlights a notable move in the company’s leadership-owned equity and may draw attention from investors tracking insider activity and executive confidence in the firm’s future performance.

Recent Updates on CBT stock

Cabot shares reacted to its Q3 earnings, where adjusted EPS modestly beat consensus and revenue topped expectations, supported by strong Performance Chemicals and battery materials growth. Management also tightened FY26 EPS guidance, signaling improved confidence despite pressures in Reinforcement Materials, raw‑material volatility and geopolitical risks.

Analysts’ price target changes reflected this mixed picture: Truist cited resilient execution and growth momentum, especially in battery materials and Performance Chemicals, while UBS focused on the earnings decline in Reinforcement Materials, anticipated margin normalization and ongoing market uncertainty. Both moves were driven by the latest earnings call, revised guidance, and segment‑level outlook rather than any new corporate actions.

Spark’s Take on CBT Stock

According to Spark, TipRanks’ AI Analyst, CBT is a Outperform.

CBT scores 75 primarily due to improved financial strength (significant deleveraging and solid margins) and constructive technical positioning (price above major moving averages with positive MACD). The score is tempered by weaker recent earnings and free-cash-flow momentum, while valuation is reasonable and the latest call was modestly positive on guidance and battery materials progress but highlighted Reinforcement Materials pressure and near-term margin/cash volatility.

To see Spark’s full report on CBT stock,
click here.

More about Cabot

YTD Price Performance: 31.92%

Average Trading Volume: 545,215

Technical Sentiment Signal: Strong Buy

Current Market Cap: $4.52B

Login to unlock1,795characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Cabot

Cabot

USCBT

-1.21%

Truist Financial

Truist Financial

USTFC

UBS Group AG

UBS Group AG

USUBS